At a $423M market cap with a Forward P/E of 5.9, the market is clearly pricing in distress rather than recovery. The absence of a trailing P/E alongside EPS of 18.1 and an expected EPS Next Year of -$0.21 signals a sharp earnings collapse, which explains the compressed multiple. A Price/Book of 0.7 and Price/Sales of 0.2 scream deep value, but the Altman Z-Score of 2 places the company in the gray zone of financial stress, not safety. This is not a clean GARP story—it’s a balance-sheet-sensitive turnaround trading at a discount because the market questions earnings durability and solvency resilience.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.